CN1064245C - Medicine for hyperosteogeny - Google Patents

Medicine for hyperosteogeny Download PDF

Info

Publication number
CN1064245C
CN1064245C CN96109804A CN96109804A CN1064245C CN 1064245 C CN1064245 C CN 1064245C CN 96109804 A CN96109804 A CN 96109804A CN 96109804 A CN96109804 A CN 96109804A CN 1064245 C CN1064245 C CN 1064245C
Authority
CN
China
Prior art keywords
medicine
portions
prepared
hyperosteogeny
radix
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Expired - Fee Related
Application number
CN96109804A
Other languages
Chinese (zh)
Other versions
CN1148971A (en
Inventor
赵胜堂
徐广峰
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
Xu Guangfeng
Original Assignee
Individual
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Individual filed Critical Individual
Priority to CN96109804A priority Critical patent/CN1064245C/en
Publication of CN1148971A publication Critical patent/CN1148971A/en
Application granted granted Critical
Publication of CN1064245C publication Critical patent/CN1064245C/en
Anticipated expiration legal-status Critical
Expired - Fee Related legal-status Critical Current

Links

Landscapes

  • Medicines Containing Plant Substances (AREA)
  • Medicines Containing Material From Animals Or Micro-Organisms (AREA)

Abstract

The present invention relates to a medicine for treating hyperosteogeny, which is characterized in that the medicine is prepared from the following Chinese herbal medicines by weight proportion: 1 portion of sanguis draconis, 3 portions of astragalus root, 9 portions of clematis root and 1.5 portions of prepared common monkshood daughter root to be prepared into fumigating powder. Angelica, hemlock parsley, safflower, herba saussureae involucratae, garden balsam stem and common clubmoss herb can be also added to the medicine. When the medicine is used, a certain amount of ginger tincture or etanol which has equal amount of medicinal powder is added to the medicine, and the lesion joints are fumigated by ignition. The medicine has conspicuous curative effect that osteophyte growth can be inhibited, pain can be killed, and the curing improvement rate in clinic reaches 89.5%.

Description

A kind of medicine for the treatment of hyperosteogeny
The present invention relates to Chinese herbal and crude drugs preparations, particularly is a kind of medicine for the treatment of hyperosteogeny.
Hyperosteogeny is one of arthritic typical cytopathic of bone type, and the traditional Chinese medical science is called it " rheumatism involving the bone ", and weak with age, bone arteries and veins loses and supports, disorder of QI and blood, the stasis of blood be for a long time for suffering from.Be a kind of chronic disease that the people easily sent out after the middle age, often limited because of pressuring nerve, the concurrent limb activity of blood vessel face, cause adverse consequences.Beg the present, this sick pathogenic factor is not understood more do not have ideal medicine and Therapeutic Method as yet both at home and abroad, existing treatment means, weight person is with the excision focus, but easily recurrence.Medicine still has Chinese patent application number 93117141 disclosed oral honeyed pill and Chinese patent application number 94100274 disclosed application compress etc. then except that general analgesic ending disease medicine and the penicillin.
The purpose of this invention is to provide the bony spur that the softening hyperosteogeny of a kind of energy forms, suppress its growth course, cause the medicine of the treatment hyperosteogeny that the patient fully recovers.
For the medicine of finishing the treatment hyperosteogeny that goal of the invention develops is to be that the stifling of raw material looses with the Chinese herbal medicine, and its composition is Sanguis Draxonis, the Radix Astragali, Radix Clematidis and Radix Aconiti Lateralis Preparata, and weight ratio is 1: 3: 9 between the component: 1.5.Because the present invention reuses Radix Clematidis and helps with Sanguis Draxonis, and the merit of blood circulation promoting and blood stasis dispelling, hard masses softening and resolving is arranged, Radix Aconiti Lateralis Preparata is dredged channels and activating collaterals, numbness relieving and pain relieving; And Radix Astragali benefiting QI for strengthening the superficies.Stifling the loosing of making, with local physical property administration, transdermal is gone into body, and volatilization absorbs fast, the focus of can going directly.
Through clinical verification and zoopery, this medicine is non-stimulated to skin, non-toxic reaction, can improve local microcirculation, and the pain due to the inflammation is had analgesic activity, and growth has inhibitory action, clinical cure improvement rate 89.5% to bony spur.
For strengthening hemopoietic of the present invention, invigorating blood circulation and the blood stasis dispelling function, in component, can increase Radix Angelicae Sinensis, Rhizoma Chuanxiong, Flos Carthami and Herba Saussureae Involueratae.
Dredge the channels and activating collaterals function for strengthening the present invention, further improve curative effect, also can add Herba speranskiae tuberculatae and Herba Lycopodii.
Below be embodiments of the invention.
Embodiment 1, and the 3kg Radix Astragali, 9kg Radix Clematidis are prepared lixiviating solution, adds the 1kg fine powder of dragons blood, places 2 hours in 60 ℃, mixes well with the coarse powder of 1.5kg Radix Aconiti Lateralis Preparata, dry pack is standby again.Its usage: with rice vinegar the clean towel of knot is squirted, put metal rack into, the powder 20g that gets it filled lights after pouring equivalent ginger tincture or ethanol into, places the focus joint stifling, each 15 to 20 minutes.
Embodiment 2, extracting solution is soaked in the 3kg Radix Astragali, the preparation of 9kg Radix Clematidis, add the 1kg fine powder of dragons blood, placed 2 hours in 60 ℃, be ground into coarse powder with 1.5kg Radix Aconiti Lateralis Preparata, 1kg Radix Angelicae Sinensis, 2kg Rhizoma Chuanxiong, 1kg Flos Carthami and 1.5kg Herba Saussureae Involueratae again, mix with lixiviating solution and mix well the branch pack.Add during use and fumigate after equivalent ginger tincture or ethanol are lighted.
Embodiment 3, extracting solution is soaked in the 3kg Radix Astragali, the preparation of 9kg Radix Clematidis, add the 1kg fine powder of dragons blood, placed 2 hours in 60 ℃, make coarse powder with 1.5kg Radix Aconiti Lateralis Preparata, 1.5kg Radix Angelicae Sinensis, 2kg Rhizoma Chuanxiong, 1.5kg Flos Carthami and 1kg Herba Saussureae Involueratae, 2.5kg Herba speranskiae tuberculatae, 2kg Herba Lycopodii again, mix well with lixiviating solution, dryly divide pack standby.Adding equivalent ginger tincture or ethanol are lighted stifling during use.

Claims (3)

1, a kind of medicine for the treatment of hyperosteogeny is characterized in that said medicine looses for stifling, and composition is Sanguis Draxonis, the Radix Astragali, Radix Clematidis and Radix Aconiti Lateralis Preparata, and the component weight ratio is 1: 3: 9: 1.5.
2, the medicine of treatment hyperosteogeny according to claim 1 is characterized in that its composition also comprises Radix Angelicae Sinensis, Rhizoma Chuanxiong, Flos Carthami, Herba Saussureae Involueratae.
3, the medicine of treatment hyperosteogeny according to claim 1 and 2 is characterized in that its composition also comprises Herba speranskiae tuberculatae, Herba Lycopodii.
CN96109804A 1996-09-17 1996-09-17 Medicine for hyperosteogeny Expired - Fee Related CN1064245C (en)

Priority Applications (1)

Application Number Priority Date Filing Date Title
CN96109804A CN1064245C (en) 1996-09-17 1996-09-17 Medicine for hyperosteogeny

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
CN96109804A CN1064245C (en) 1996-09-17 1996-09-17 Medicine for hyperosteogeny

Publications (2)

Publication Number Publication Date
CN1148971A CN1148971A (en) 1997-05-07
CN1064245C true CN1064245C (en) 2001-04-11

Family

ID=5120622

Family Applications (1)

Application Number Title Priority Date Filing Date
CN96109804A Expired - Fee Related CN1064245C (en) 1996-09-17 1996-09-17 Medicine for hyperosteogeny

Country Status (1)

Country Link
CN (1) CN1064245C (en)

Families Citing this family (6)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
CN1327871C (en) * 2004-06-30 2007-07-25 谭礼明 Steaming medicinal liquor for treating intervertebral disc protrusion and hyperosteogeny
CN101543623B (en) * 2009-05-04 2011-08-24 王国森 Green healthy bone-strengthening capsule
CN103142864A (en) * 2013-03-01 2013-06-12 溧阳市天目湖保健品有限公司 Plaster for treating joint gall
CN105327156A (en) * 2015-12-01 2016-02-17 徐腾 Fuming traditional Chinese medicine composition for treating osteoarthropathy and preparation method thereof
CN107260918A (en) * 2016-04-08 2017-10-20 范付春 A kind of Chinese medicine preparation for treating osteoproliferation
CN114886984A (en) * 2022-04-13 2022-08-12 赵峰 Medicine for treating hyperosteogeny

Citations (2)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
CN1068962A (en) * 1992-07-13 1993-02-17 李去病 The preparation technology of yugusan
CN1097131A (en) * 1993-07-07 1995-01-11 汪孝文 Gulingdan pill

Patent Citations (2)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
CN1068962A (en) * 1992-07-13 1993-02-17 李去病 The preparation technology of yugusan
CN1097131A (en) * 1993-07-07 1995-01-11 汪孝文 Gulingdan pill

Non-Patent Citations (1)

* Cited by examiner, † Cited by third party
Title
《实用中西医结合杂志》1991,4(9) 1991.1.1 吴大勇,中药制膏贴敷治疗骨质增生700例 *

Also Published As

Publication number Publication date
CN1148971A (en) 1997-05-07

Similar Documents

Publication Publication Date Title
CN111514262B (en) Self-heating acupoint application traditional Chinese medicine composition and preparation method thereof
CN102309723B (en) Traditional Chinese medicine composition for treating arthralgia and preparation method of ointment thereof
CN1237427A (en) Adhesive plaster for curing prolapse of lumbar intervertebral disk
CN1322885C (en) Plaster medicine composition with multiple purpose for treating affection pain due to dampness
CN101983710B (en) Medicine for external application in orthopedics, production method and application method thereof
CN1064245C (en) Medicine for hyperosteogeny
CN102512519A (en) Medicinal moxa roll for treating osteoporosis and preparation method thereof
CN104435783A (en) Energy health-preserving moxibustion compound and using method thereof
CN101352517B (en) Chinese medicine for treating lumbocrural pain and preparation method thereof
CN114452347A (en) A composition for treating pain in neck, shoulder, waist and leg, and prolapse of lumbar intervertebral disc, and its preparation method
CN1052415C (en) Painless bonesetting medicine
CN105535333A (en) Traditional Chinese medicine composition and preparation for treating lymphatic lesions, as well as preparation method and application thereof
CN101623420B (en) Chinese medicament application plaster for treating benign tumor
CN104758527A (en) Traditional Chinese medicine composition for treating pain in waists and legs
CN1127664A (en) External use medicinal bag for treating acute and chronic gastritis and cholecystitis, and preparing method thereof
CN103585257A (en) Traditional Chinese medicine powder for treating fractures
CN1060073C (en) Externally used medicine bag for curing chronic pelvic infection, endometriosis, chronic cervicitis and menalgia and its making process
CN1153578C (en) Medicine for treating bone fracture and osteopathy
CN100536907C (en) Osteopathy treating Chinese medicine
CN105194411A (en) Formula of traditional Chinese medicine for treating scapulobumeral periarthritis
CN104958380A (en) Preparation method of medicinal liquor for treating sciatica
CN105560537A (en) Medicine composition for treating osteoartritis and preparation method thereof
CN100360158C (en) Chinese medicine prepn for promoting blood circulation and dredging meridian passage
CN110876792A (en) Borneol plaster for relaxing muscles and tendons and activating collaterals
CN111035749A (en) Traditional Chinese medicine mud film for mud moxibustion and preparation method thereof

Legal Events

Date Code Title Description
C10 Entry into substantive examination
SE01 Entry into force of request for substantive examination
C06 Publication
PB01 Publication
C14 Grant of patent or utility model
GR01 Patent grant
C56 Change in the name or address of the patentee

Owner name: XU GUANGFENG

Free format text: FORMER NAME OR ADDRESS: ZHAO SHENGTANG

Free format text: NO CO-PATENTEE; FORMER NAME OR ADDRESS: XU GUANGFENG

CP03 Change of name, title or address

Address after: 100043 bone disease research clinic, No. 12, Gucheng street, Beijing, Shijingshan District

Patentee after: Xu Guangfeng

Address before: 062150 Botou Hospital of traditional Chinese medicine, No. 344 Xiguan Street, Hebei, Botou

Co-patentee before: Xu Guangfeng

Patentee before: Zhao Shengtang

PE01 Entry into force of the registration of the contract for pledge of patent right

Denomination of invention: Medicine for treating hyperosteogeny

Effective date of registration: 20110726

Granted publication date: 20010411

Pledgee: Beijing Huaxia Industrial Investment Company limited by guarantee

Pledgor: Xu Guangfeng

Registration number: 2011990000288

DD01 Delivery of document by public notice

Addressee: Xu Guangfeng

Document name: Notification to Pay the Fees

PC01 Cancellation of the registration of the contract for pledge of patent right

Date of cancellation: 20121220

Granted publication date: 20010411

Pledgee: Beijing Huaxia Industrial Finance Company limited by guarantee

Pledgor: Xu Guangfeng

Registration number: 2011990000288

PLDC Enforcement, change and cancellation of contracts on pledge of patent right or utility model
PM01 Change of the registration of the contract for pledge of patent right

Change date: 20121220

Registration number: 2011990000288

Pledgee after: Beijing Huaxia Industrial Finance Company limited by guarantee

Pledgee before: Beijing Huaxia Industrial Investment Company limited by guarantee

DD01 Delivery of document by public notice

Addressee: Xu Guangfeng

Document name: Notification of Termination of Patent Right

C17 Cessation of patent right
CF01 Termination of patent right due to non-payment of annual fee

Granted publication date: 20010411

Termination date: 20120917